Comparative Plasma and Cerebrospinal Fluid Pharmacokinetics of Paracetamol After Intravenous and Oral Administration

被引:29
|
作者
Langford, Roger A. [1 ,8 ]
Hogg, Malcolm [1 ,2 ]
Bjorksten, Andrew R. [1 ,2 ,3 ]
Williams, Daryl L. [1 ,2 ,4 ]
Leslie, Kate [1 ,2 ,5 ,6 ]
Jamsen, Kris [7 ]
Kirkpatrick, Carl [7 ]
机构
[1] Royal Melbourne Hosp, Dept Anaesthesia & Pain Management, Melbourne, Vic, Australia
[2] Univ Melbourne, Anaesthesia Perioperat & Pain Med Unit, Melbourne, Vic, Australia
[3] Univ Melbourne, Dept Pharmacol & Therapeut, Melbourne, Vic, Australia
[4] Univ Melbourne, Dept Med, Melbourne, Vic, Australia
[5] Univ Melbourne, Dept Pharmacol, Melbourne, Vic, Australia
[6] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia
[7] Monash Univ, Fac Pharm & Pharmaceut Sci, Ctr Med Use & Safety, Melbourne, Vic, Australia
[8] Royal Cornwall Hosp, Dept Anaesthesia, Truro TR1 3LJ, Cornwall, England
来源
ANESTHESIA AND ANALGESIA | 2016年 / 123卷 / 03期
关键词
ACETAMINOPHEN; CHILDREN; MECHANISMS; ANALGESIA; PAIN;
D O I
10.1213/ANE.0000000000001463
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
BACKGROUND: We compared plasma and cerebrospinal fluid (CSF) pharmacokinetics of paracetamol after intravenous (IV) and oral administration to determine dosing regimens that optimize CSF concentrations. METHODS: Twenty-one adult patients were assigned randomly to 1 g IV, 1 g oral or 1.5 g oral par6cetamol. An IV cannula and lumbar intrathecal catheter were used to sample venous blood and CSF, respectively, over 6 hours. The plasma and CSF maximum concentrations (C-max), times to maximum concentrations (Tmax), and area under the plasma and CSF concentration-time curves (AUCs) were calculated using noncompartmental techniques. Significance was defined by P <.0167 (Bonferroni correction for 3 comparisons for each parameter). Probability (X < Y) (p") with Bonferroni corrected 95% confidence intervals (Cis) were calculated (Cls including 0.5 meet the null hypothesis). 'Results are presented as median (range) or p '' (CI). P values are listed as 1 g IV vs 1 g orally, 1 g IV vs 1.5 g orally and 1 g orally vs 1.5 g orally, respectively. RESULTS: Wide variation in measured paracetamol concentrations was observed, especially in the oral groups. The median plasma C-max in the 1 g IV group was significantly greater than the oral groups. In contrast, the median CSF C-max was not different between groups. The median plasma T-max in the 1 g IV group was 105 and 75 minutes earlier than in the 1 and 1.5 g oral groups. The median CSF T-max was not significantly different between groups. The median plasma AUC (total) was not significantly different between groups; however, in the first hour, the median plasma AUC was significantly greater in the IV group than in the oral groups. In the second hour, there was no difference between groups. The median CSF AUC (total) did not significantly differ between groups; however, in the first hour, the median CSF AUC was significantly greater in the IV compared with the orally groups. In the second hour, there was no difference between groups. Our analysis indicated that the median C-max, T-max, and AUC values lacked precision because of small sample sizes. CONCLUSIONS: Peak plasma.concentrations were greater and reached earlier after IV than oral dosing. Evidence for differences in CSF C-max and T-max was lacking because of the small size of this study.
引用
收藏
页码:610 / 615
页数:6
相关论文
共 50 条
  • [11] Plasma and cerebrospinal fluid pharmacokinetics of pemetrexed after intravenous administration in non-human primates
    Stacie L. Stapleton
    Joel M. Reid
    Patrick A. Thompson
    Matthew M. Ames
    Renee M. McGovern
    Leticia McGuffey
    Jed Nuchtern
    Robert Dauser
    Susan M. Blaney
    [J]. Cancer Chemotherapy and Pharmacology, 2007, 59 : 461 - 466
  • [12] Plasma and cerebrospinal fluid pharmacokinetics of SU5416 after intravenous administration in nonhuman primates
    Jamie Renbarger
    Alexander Aleksic
    Leticia McGuffey
    Robert Dauser
    Stacey Berg
    Susan Blaney
    [J]. Cancer Chemotherapy and Pharmacology, 2004, 53 (1) : 39 - 42
  • [13] Plasma and cerebrospinal fluid pharmacokinetics of pemetrexed after intravenous administration in non-human primates
    Stapleton, Stacie L.
    Reid, Joel M.
    Thompson, Patrick A.
    Ames, Matthew M.
    McGovern, Renee M.
    McGuffey, Leticia
    Nuchtern, Jed
    Dauser, Robert
    Blaney, Susan M.
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 59 (04) : 461 - 466
  • [14] The plasma and cerebrospinal fluid pharmacokinetics of sorafenib after intravenous administration in non-human primates
    Kim, AeRang
    McCully, Cindy
    Cruz, Rafael
    Cole, Diane E.
    Fox, Elizabeth
    Balis, Frank M.
    Widemann, Brigitte C.
    [J]. INVESTIGATIONAL NEW DRUGS, 2012, 30 (02) : 524 - 528
  • [15] Plasma and cerebrospinal fluid pharmacokinetics of SU5416 after intravenous administration in nonhuman primates
    Renbarger, J
    Aleksic, A
    McGuffey, L
    Dauser, R
    Berg, S
    Blaney, S
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2004, 53 (01) : 39 - 42
  • [16] The plasma and cerebrospinal fluid pharmacokinetics of satraplatin after intravenous administration in non-human primates
    Marcus, Leigh J.
    Murphy, Robert F.
    Fox, Elizabeth
    McCully, Cynthia L.
    Cruz, Rafeal
    Warren, Kathy
    Balis, Frank M.
    Widemann, Brigitte C.
    Meyer, Thorsten
    [J]. CANCER RESEARCH, 2010, 70
  • [17] Paracetamol (acetaminophen) penetrates readily into the cerebrospinal fluid of children after intravenous administration
    Kumpulainen, Elina
    Kokki, Hannu
    Halonen, Toivo
    Heikkinen, Marja
    Savolainen, Jouko
    Laisalmi, Merja
    [J]. PEDIATRICS, 2007, 119 (04) : 766 - 771
  • [18] Pharmacodynamic effects and relationships to plasma and oral fluid pharmacokinetics after intravenous cocaine administration
    Ellefsen, Kayla N.
    Concheiro, Marta
    Pirard, Sandrine
    Gorelick, David A.
    Huestis, Marilyn A.
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2016, 163 : 116 - 125
  • [19] Plasma and cerebrospinal fluid pharmacokinetics of doxil after intravenous administration in adults with primary CNS lymphoma.
    Higham, Christine
    Murphy, Robert F.
    Bhaumik, Sucharita
    Dunleavy, Kieron
    Wilson, Wyndham Hopkins
    Widemann, Brigitte C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [20] Plasma pharmacokinetics of quinocetone in ducks after oral and intravenous administration
    Qiu, M.
    Hao, Z.
    Zhang, R.
    Cui, L.
    Wang, C.
    Qu, S.
    Yuan, S.
    Bai, Y.
    [J]. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2018, 41 (01) : 142 - 147